DB
HCAT icon

Dmitry Balyasny’s Health Catalyst HCAT Stock Holding History

Dmitry Balyasny’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-110,491
Closed -$417K – 3129
2025
Q2 		$417K Sell
110,491
-37,649
-25% -$148K ﹤0.01% 2360
2025
Q1 		$671K Buy
+148,140
New +$784K ﹤0.01% 2167
2024
Q3 		– Sell
-25,858
Closed -$165K – 2910
2024
Q2 		$165K Buy
+25,858
New +$166K ﹤0.01% 2363
2024
Q1 		– Sell
-279,978
Closed -$2.59M – 2812
2023
Q4 		$2.59M Sell
279,978
-220,034
-44% -$1.8M ﹤0.01% 1371
2023
Q3 		$5.06M Buy
500,012
+82,024
+20% +$979K 0.01% 1103
2023
Q2 		$5.22M Sell
417,988
-633,978
-60% -$7.55M 0.01% 1035
2023
Q1 		$12.3M Sell
1,051,966
-603,980
-36% -$7.7M 0.03% 703
2022
Q4 		$17.6M Buy
1,655,946
+516,367
+45% +$4.99M 0.05% 535
2022
Q3 		$11.1M Buy
1,139,579
+189,654
+20% +$2.51M 0.03% 643
2022
Q2 		$13.8M Buy
+949,925
New +$16.2M 0.04% 541
2022
Q1 		– Sell
-150,005
Closed -$5.94M – 2623
2021
Q4 		$5.94M Buy
+150,005
New +$6.84M 0.02% 796
2020
Q4 		– Sell
-11,982
Closed -$439K – 1484
2020
Q3 		$439K Buy
+11,982
New +$407K ﹤0.01% 1126
2019
Q4 		– Sell
-20,611
Closed -$652K – 1293
2019
Q3 		$652K Buy
+20,611
New +$811K ﹤0.01% 906

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dmitry Balyasny's HCAT Position: Q3 2025 in Review

Dmitry Balyasny sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 110,491 shares — an estimated $417K sold.

Dmitry Balyasny first reported a position in HCAT in Q3 2019 and held it in 13 quarters. The position peaked at $17.6M in Q4 2022. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Dmitry Balyasny reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Dmitry Balyasny sold 110,491 Health Catalyst shares in Q3 2025, an estimated $417K.
  • Dmitry Balyasny first reported a position in Health Catalyst in Q3 2019 and held it in 13 quarters.
  • Dmitry Balyasny's Health Catalyst position peaked at $17.6M in Q4 2022.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.